Key result
DNA polymerase β loss delays atherosclerosis in mice and inhibits VSMC migration via YY1/TGF-β1 suppression.
Why the study?
Excessive migration of vascular smooth muscle cells triggers atherosclerosis development, but the underlying mechanism remains unclear.
Does DNA polymerase β knockdown reduce atherosclerosis development and VSMC migration in ApoE−/− mice and hCASMCs?
Does DNA polymerase β knockdown reduce atherosclerosis development and VSMC migration in ApoE−/− mice and hCASMCs?
Loss of DNA polymerase β delays atherosclerosis by inhibiting vascular smooth muscle cell migration via the YY1/TGF-β1/POSTN pathway.
Identifies a novel therapeutic target for atherosclerosis; leaves open whether modulating DNA polymerase β can safely translate to.
Atherosclerosis (AS) is an inflammatory disease characterized by arterial inflammation. One important trigger for AS development is the excessive migration of vascular smooth muscle cells (VSMCs); however, the mechanism underlying this phenomenon remains unclear. Therefore, we investigated the role of DNA polymerase β (Pol β), a crucial enzyme involved in base excision repair, VSMC migration, and subsequent AS development. In this study, we revealed a significant increase in Pol β content within AS plaques in ApoE−/−Pol β+/+ mice. In vitro experiments demonstrated a significant decrease in hCASMC viability and migration ability upon Pol β knockdown, whereas the subsequent recovery of Pol β expression reversed this effect. Moreover, our investigations revealed that Pol β knockdown leads to the inhibition of the POSTN gene transcription by suppressing the YY1/TGF-β1 pathway, resulting in the decreased expression of the protein periostin during VSMC migration. Collectively, our findings provide insights into the role of Pol β in AS development, offering a novel approach for the clinical treatment of cardiovascular diseases.
No takes yet. Share an insight, caveat, or question.
Zhao et al. (2024) studied Atherosclerosis. DNA Polymerase β (Pol β) knockdown vs. Control / Pol β expression was evaluated on Atherosclerosis development and vascular smooth muscle cell migration. Loss of DNA Polymerase β delays atherosclerosis in ApoE−/− mice and inhibits vascular smooth muscle cell migration by suppressing the YY1/TGF-β1 pathway and POSTN gene transcription.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: